ऑस्ट्रेलिया - अंग्रेज़ी - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - citrate ions; glucose; chloride ions; potassium ions; magnesium ions; sodium ions; phosphate ions; sulfate ions - oral solution/suspension - citrate ions ungrouped active 34.5 g/l; glucose carbohydrate active 260.0 g/l; chloride ions mineral-chlorine active 43.33 g/l; potassium ions mineral-potassium active 30.36 g/l; magnesium ions mineral-magnesium active 2.98 g/l; sodium ions mineral-sodium active 27.55 g/l; phosphate ions mineral-phosphorus active 17.37 g/l; sulfate ions mineral-sulfur active 11.76 g/l - nutrition & metabolism - dog | dog - greyhound | bitch | castrate | puppy | racing greyhound - dehydration | electrolyte replacement

कनाडा - अंग्रेज़ी - Health Canada

odan laboratories ltd - chloral hydrate - syrup - 500mg - chloral hydrate 500mg - miscellaneous anxiolytics sedatives and hypnotics

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - chloral hydrate - oral solution - 100mg/1ml

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - chloral hydrate - oral solution - 40mg/1ml

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - ciclosporin, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: dl-alpha-tocopherol; ethanol; corn glycerides; propylene glycol; peg-40 hydrogenated castor oil - as an immunosuppressive agent for the prevention of graft rejection following kidney, liver and heart allogeneic transplantation. for induction and/or maintenance of remission in the nephrotic syndrome. cyclosporin is not a first-line agent. its use should be restricted to occasions when steroids and cystostatic drugs have failed, or are not tolerated, or are considered inappropriate, and when renal function is unimpaired (see warnings). for the treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting antirheumatic agents (including methotrexate) are inappropriate or ineffective. in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate and the disease has caused a significant interference with quality of life. additional indication from 11 june 1997: for the treatment of severe atopic dermatitis when other treatment is ineffective or inappropriate.

केन्या - अंग्रेज़ी - Pharmacy and Poisons Board

krishna chemists ltd 3rd floor metrix hardware, lusaka road, - deflazacort oral suspension - oral liquid - deflazacort oral suspension 6 mg/5 ml - deflazacort

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - glucose monohydrate,potassium chloride,sodium chloride,sodium acid citrate -

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

world health organisation formula) (special order - glucose anhydrous; potassium chloride; sodium chloride; sodium citrate - oral powder - 13.5gram ; 1.5gram ; 2.6gram ; 2.9gram

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

trion pharma ltd - oral liquid

यूनाइटेड किंगडम - अंग्रेज़ी - MHRA (Medicines & Healthcare Products Regulatory Agency)

flavour not specified - oral liquid